On January 17, 2024, the company announced that it has extended its plan duration till June 30, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | +0.71% | -6.00% | -47.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.78% | 26.52M | |
+9.42% | 115B | |
+11.84% | 106B | |
-14.15% | 21.84B | |
-1.05% | 21.96B | |
-5.29% | 19.21B | |
-38.29% | 17.71B | |
-4.16% | 18.08B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ENLV Stock
- News Enlivex Therapeutics Ltd.
- Enlivex Therapeutics Ltd.'s Equity Buyback Plan Extended till June 30, 2024.